导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 21.16% | 193/1050 |
| 近一周 | -0.83% | 106/1104 |
| 近一月 | -6.15% | 739/1102 |
| 近一季 | 32.85% | 9/1092 |
| 近半年 | 27.31% | 91/1070 |
| 近一年 | 5.03% | 471/1018 |
| 近两年 | 58.35% | 443/926 |
| 近三年 | 27.31% | 411/834 |
| 成立以来 | 147.32% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.29% 511/1070 |
5.72% 609/1101 |
- - |
- - |
| 2025 | 21.29% 643/1065 |
4.81% 424/1014 |
12.18% 62/1038 |
21.43% 563/1050 |
-15.05% 984/1065 |
| 2024 | -14.48% 845/1011 |
-9.06% 744/960 |
-7.94% 783/983 |
11.73% 478/991 |
-8.58% 848/1011 |
| 2023 | -9.72% 322/952 |
1.26% 555/880 |
-6.67% 623/895 |
-3.54% 230/915 |
-0.96% 166/952 |
| 2022 | -18.35% 268/867 |
-14.66% 243/773 |
5.60% 487/806 |
-15.08% 573/845 |
6.69% 142/867 |
| 2021 | -1.69% 376/740 |
-2.34% 234/580 |
26.47% 68/659 |
-11.62% 546/704 |
-9.93% 658/740 |
| 2020 | 96.29% 42/554 |
11.53% 38/419 |
47.21% 9/466 |
5.94% 346/517 |
12.85% 257/554 |
| 2019 | 72.67% 29/410 |
28.95% 430/1146 |
6.46% 27/1228 |
16.91% 30/390 |
7.59% 257/410 |
| 2018 | -8.63% 5/349 |
- - |
0.33% 73/990 |
-8.69% 686/1000 |
-13.27% 766/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 交银医药创新股票A VS. 东吴新产业精选股票A(580008) |